Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1636, 2008-01, pp. : 22-22
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Rexin-G granted orphan drug status for third indication in US.
Inpharma, Vol. 1, Iss. 1647, 2008-01 ,pp. :
Nimotuzumab [Theraloc] granted orphan drug status in Europe.
Inpharma, Vol. 1, Iss. 1636, 2008-01 ,pp. :
US orphan drug designation granted for MGCD0103
Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. :
Pfizer's SU 11248 has been granted orphan drug status by the European Commission
Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. :
SB 1518 gains orphan drug status for MPDs in US.
Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. :